Exosomes from miRNA‐126‐modified endothelial progenitor cells alleviate brain injury and promote functional recovery after stroke

• DOI: 10.1111/cns.13455
• Publication Date: 2020-10-03T09:47:27Z
• Authors: Jinju Wang; Shuzhen Chen; Wenfeng Zhang; Yanfang Chen; Ji C. Bihl
• Keywords: exosomes; Exosomes; Medical Toxicology; Mice; 03 medical and health sciences; brain injuries; ischemic stroke; Medicine and Health Sciences; Animals; Infusions, Intravenous; Cells, Cultured; endothelial progenitor cells; Endothelial Progenitor Cells; 0303 health sciences; diabetes; Recovery of function; Original Articles; Recovery of Function; microRNAs; Chemicals and Drugs; Mice, Inbred C57BL; Stroke; MicroRNAs; Brain Injuries; miRNAs

AbstractAimsWe previously showed that the protective effects of endothelial progenitor cells (EPCs)‐released exosomes (EPC‐EXs) on endothelium in diabetes. However, whether EPC‐EXs are protective in diabetic ischemic stroke is unknown. Here, we investigated the effects of EPC‐EXs on diabetic stroke mice and tested whether miR‐126 enriched EPC‐EXs (EPC‐EXsmiR126) have enhanced efficacy.MethodsThe db/db mice subjected to ischemic stroke were intravenously administrated with EPC‐EXs 2 hours after ischemic stroke. The infarct volume, cerebral microvascular density (MVD), cerebral blood flow (CBF), neurological function, angiogenesis and neurogenesis, and levels of cleaved caspase‐3, miR‐126, and VEGFR2 were measured on day 2 and 14.ResultsWe found that (a) injected EPC‐EXs merged with brain endothelial cells, neurons, astrocytes, and microglia in the peri‐infarct area; (b) EPC‐EXsmiR126 were more effective than EPC‐EXs in decreasing infarct size and increasing CBF and MVD, and in promoting angiogenesis and neurogenesis as well as neurological functional recovery; (c) These effects were accompanied with downregulated cleaved caspase‐3 on day 2 and vascular endothelial growth factor receptor 2 (VEGFR2) upregulation till day 14.ConclusionOur results indicate that enrichment of miR126 enhanced the therapeutic efficacy of EPC‐EXs on diabetic ischemic stroke by attenuating acute injury and promoting neurological function recovery.